HIT Consultant June 10, 2021
Jasmine Pennic

What You Should Know:

Transcarent, a San Francisco, CA-based provider of consumer-directed healthcare to self-insured employers, just announced $58M in Series B funding led by many of the top health and tech investors, bringing its total funding to $98M.

– Led by CEO Glen Tullman, an industry veteran who previously led Livongo and Allscripts, Transcarent is overhauling the self-insured healthcare industry – a market that is long overdue for disruption. Despite numerous efforts and billions of dollars fueling a digital health revolution, employer healthcare costs continue to spiral out of control.

To solve it, Transcarent’s approach is to shift power back to employers who’ve traditionally not had much leverage to negotiate better deals with providers, shouldering much more of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Insurance, Investments, Self-insured, Technology, Trends
Smartwatches reveal insights into psychiatric illnesses and genetic links
Digital therapeutics: Exploring the road to commercialization across international markets
ATA to Trump administration: Let’s talk telehealth
B2C2B models gaining traction in HealthTech
Red Rover Health Raises $4 Million in Funding to Grow Healthcare App Store Platform

Share This Article